Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

The influence of antipsychotic treatment on brain reward system reactivity in schizophrenia patients.

Kirsch P, Ronshausen S, Mier D, Gallhofer B.

Pharmacopsychiatry. 2007 Sep;40(5):196-8.

PMID:
17874350
2.

Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine.

Schlagenhauf F, Juckel G, Koslowski M, Kahnt T, Knutson B, Dembler T, Kienast T, Gallinat J, Wrase J, Heinz A.

Psychopharmacology (Berl). 2008 Mar;196(4):673-84. Epub 2007 Dec 21.

PMID:
18097655
3.

Altered reward functions in patients on atypical antipsychotic medication in line with the revised dopamine hypothesis of schizophrenia.

Walter H, Kammerer H, Frasch K, Spitzer M, Abler B.

Psychopharmacology (Berl). 2009 Sep;206(1):121-32. doi: 10.1007/s00213-009-1586-4. Epub 2009 Jun 12.

PMID:
19521678
4.

Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics.

Juckel G, Schlagenhauf F, Koslowski M, Filonov D, Wüstenberg T, Villringer A, Knutson B, Kienast T, Gallinat J, Wrase J, Heinz A.

Psychopharmacology (Berl). 2006 Aug;187(2):222-8. Epub 2006 May 24.

PMID:
16721614
5.

Review the role of dopamine D4 receptors in schizophrenia and antipsychotic action.

Sanyal S, Van Tol HH.

J Psychiatr Res. 1997 Mar-Apr;31(2):219-32. Review.

PMID:
9278187
6.

Dopaminergic modulation of the reward system in schizophrenia: a placebo-controlled dopamine depletion fMRI study.

da Silva Alves F, Bakker G, Schmitz N, Abeling N, Hasler G, van der Meer J, Nederveen A, de Haan L, Linszen D, van Amelsvoort T.

Eur Neuropsychopharmacol. 2013 Nov;23(11):1577-86. doi: 10.1016/j.euroneuro.2013.06.008. Epub 2013 Aug 24.

7.

Striatal response to reward anticipation: evidence for a systems-level intermediate phenotype for schizophrenia.

Grimm O, Heinz A, Walter H, Kirsch P, Erk S, Haddad L, Plichta MM, Romanczuk-Seiferth N, Pöhland L, Mohnke S, Mühleisen TW, Mattheisen M, Witt SH, Schäfer A, Cichon S, Nöthen M, Rietschel M, Tost H, Meyer-Lindenberg A.

JAMA Psychiatry. 2014 May;71(5):531-9. doi: 10.1001/jamapsychiatry.2014.9.

PMID:
24622944
8.

Dysfunction of ventral striatal reward prediction in schizophrenia.

Juckel G, Schlagenhauf F, Koslowski M, Wüstenberg T, Villringer A, Knutson B, Wrase J, Heinz A.

Neuroimage. 2006 Jan 15;29(2):409-16. Epub 2005 Sep 1.

PMID:
16139525
9.

Antipsychotic dose modulates behavioral and neural responses to feedback during reinforcement learning in schizophrenia.

Insel C, Reinen J, Weber J, Wager TD, Jarskog LF, Shohamy D, Smith EE.

Cogn Affect Behav Neurosci. 2014 Mar;14(1):189-201. doi: 10.3758/s13415-014-0261-3.

PMID:
24557585
10.

[Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone].

Haefliger T, Bonsack C.

Encephale. 2006 Jan-Feb;32(1 Pt 1):97-105. French.

PMID:
16633296
11.

How do the atypical antipsychotics work?

Ananth J, Burgoyne KS, Gadasalli R, Aquino S.

J Psychiatry Neurosci. 2001 Nov;26(5):385-94. Review.

12.

Antipsychotic drug mechanisms and neurotransmitter systems in schizophrenia.

Reynolds GP.

Acta Psychiatr Scand Suppl. 1994;380:36-40. Review.

PMID:
7914046
13.

Alterations of the brain reward system in antipsychotic naïve schizophrenia patients.

Nielsen MØ, Rostrup E, Wulff S, Bak N, Lublin H, Kapur S, Glenthøj B.

Biol Psychiatry. 2012 May 15;71(10):898-905. doi: 10.1016/j.biopsych.2012.02.007. Epub 2012 Mar 13.

PMID:
22418013
14.

Atypical antipsychotics: mechanism of action.

Seeman P.

Can J Psychiatry. 2002 Feb;47(1):27-38. Review.

PMID:
11873706
15.

Cigarette smoking modulates medication-associated deficits in a monetary reward task in patients with schizophrenia.

Lernbass B, Grön G, Wolf ND, Abler B.

Eur Arch Psychiatry Clin Neurosci. 2013 Sep;263(6):509-17. doi: 10.1007/s00406-012-0370-3. Epub 2012 Sep 26.

PMID:
23010839
16.

Pavlovian reward prediction and receipt in schizophrenia: relationship to anhedonia.

Dowd EC, Barch DM.

PLoS One. 2012;7(5):e35622. doi: 10.1371/journal.pone.0035622. Epub 2012 May 4.

17.

Lower striatal dopamine transporter binding in neuroleptic-naive schizophrenic patients is not related to antipsychotic treatment but it suggests an illness trait.

Mateos JJ, Lomeña F, Parellada E, Mireia F, Fernandez-Egea E, Pavia J, Prats A, Pons F, Bernardo M.

Psychopharmacology (Berl). 2007 Apr;191(3):805-11. Epub 2006 Sep 22.

PMID:
17019564
18.
19.

Anticipation of reward in a nonaversive differential conditioning paradigm and the brain reward system: an event-related fMRI study.

Kirsch P, Schienle A, Stark R, Sammer G, Blecker C, Walter B, Ott U, Burkart J, Vaitl D.

Neuroimage. 2003 Oct;20(2):1086-95.

PMID:
14568478
20.

Striatal Reward Activity and Antipsychotic-Associated Weight Change in Patients With Schizophrenia Undergoing Initial Treatment.

Nielsen MØ, Rostrup E, Wulff S, Glenthøj B, Ebdrup BH.

JAMA Psychiatry. 2016 Feb;73(2):121-8. doi: 10.1001/jamapsychiatry.2015.2582.

PMID:
26747088
Items per page

Supplemental Content

Write to the Help Desk